Results of a small study presented at the 66th American Society of Hematology Annual Meeting & Exposition suggest combining ...

The Community Oncology Alliance (COA) meetings featured expert discussions around the evolving landscape of oncology care and ...

The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Connect 2024 emphasized the transformative potential of artificial intelligence (AI) and predictive analytics in addressing ...

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...

Robin Glasgow, MBA, executive leadership advisor of Spencer Stuart, discusses the critical role of data in health care, ...

A new report from The Commonwealth Fund compares trends in health plan spending and employee costs for 2014 through 2023 ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...

ILD patients show higher prevalence of fatigue (40.7%) and EDS (35.2%) compared to healthy controls, impacting quality of ...

In part 2 of our interview, Alice W. Lee, PhD, MPH, of California State University, Fullerton, examines survival disparities ...